Sustained improvements in health-related quality of life following repeat onabotulinumtoxinA detrusor injections in patients with neurogenic detrusor overactivity: results from two phase 3 studies

Chartier-Kastler E1, Rovner E2, Chancellor M3, Corbell C4, Jin J4, Globe D4

Abstract Category

Quality of Life (QoL)

Abstract 174
Neurourology and Paediatrics
Scientific Podium Poster Session 19
Thursday 29th August 2013
14:55 - 15:00
113
Clinical Trial Detrusor Overactivity Incontinence Quality of Life (QoL)
1. Université Paris-VI, Department of Urology, Paris, France, 2. Medical University of South Carolina, Department of Urology, Charleston, SC, USA, 3. Oakland University, William Beaumont School of Medicine, Royal Oak, MI, USA, 4. Allergan, Inc, Irvine, CA, USA
Presenter
E

Emmanuel Chartier-Kastler

Links

Abstract

27/03/2024 17:48:42